AGES:LSE:LSE-iShares IV Public Limited Company - iShares Ageing Population UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 602.375

Change

0.00 (0.00)%

Market Cap

N/A

Volume

5.47K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-2.00 (-0.90%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+1.47 (+1.08%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.08 (-0.55%)

USD 562.96B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.21 (-1.18%)

USD 562.96B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.55 (-0.88%)

USD 266.08B
0QZO:LSE 0QZO

-0.70 (-0.63%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.33 (-1.11%)

USD 239.13B
0QZ3:LSE Qualcomm Inc.

-1.35 (-0.86%)

USD 202.26B
0R24:LSE Intel Corp.

-0.42 (-2.07%)

USD 196.14B

ETFs Containing AGES:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.82% 62% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.82% 61% D- 62% D
Trailing 12 Months  
Capital Gain 9.82% 62% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.82% 61% D- 62% D
Trailing 5 Years  
Capital Gain 24.77% 53% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.77% 50% F 62% D
Average Annual (5 Year Horizon)  
Capital Gain 6.98% 52% F 58% F
Dividend Return 6.98% 51% F 58% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.59% 53% F 70% C-
Risk Adjusted Return 51.37% 55% F 71% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike